Form 4: Mobix Labs Interim CEO Philip Sansone Reports Acquisition and Disposal of Securities
SEC Form 4 Filing
Interim CEO Philip Sansone reports transactions involving Mobix Labs Class A Common Stock and Stock Options.
Summary
- On April 10, 2025, Philip Sansone acquired 400,000 shares of Class A Common Stock through Restricted Stock Units (RSUs) and disposed of 10,000 and 161,758 stock options.
- On April 15, 2025, Sansone acquired an additional 600,000 shares of Class A Common Stock through RSUs.
- Following these transactions, Sansone beneficially owns 1,035,885 shares of Class A Common Stock directly.
- The RSUs vest over time, with 90% vested on the grant date and the remaining 10% vesting in equal installments until January 1, 2026.
- Delivery of shares underlying the RSUs will be deferred until certain events occur, such as separation from service, change in control, or an unforeseeable emergency.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The sentiment is neither particularly positive nor negative.
Positives
- The acquisition of shares by the Interim CEO could be seen as a positive sign of confidence in the company's future.
Negatives
- The disposal of stock options could be interpreted negatively, although it is explained as being related to the grant of RSUs.
Risks
- The deferred delivery of shares underlying the RSUs introduces uncertainty regarding when Sansone will actually receive the shares.
- The vesting schedule could impact Sansone's motivation and retention.
Future Outlook
The document does not contain specific forward-looking statements about the company's financial performance or future prospects, but it does detail the vesting schedule and conditions for the delivery of shares underlying the RSUs.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the transactions of company executives and their holdings of company securities.
Stakeholder Impact
- Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.
- Employees may be impacted by the vesting schedule of the RSUs granted to the Interim CEO.
Key Dates
| Date | Description |
|---|---|
| 04/04/2032 | Expiration date of some stock options |
| 04/10/2025 | Date of initial RSU grant and stock option disposal |
| 04/15/2025 | Date of second RSU grant |
| 05/12/2025 | Date of signature on the Form 4 |
| 08/10/2030 | Expiration date of some stock options |
| 09/30/2025 | Date when some stock options would have been fully vested and exercisable |
| 01/01/2026 | Final vesting date for RSUs |
Keywords
Mobix Labs, Philip Sansone, Form 4, Securities, Ownership, RSU, Stock Options, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.